Nirmatrelvir

Nirmatrelvir is a prescription medication used to treat adults with chronic hepatitis C virus (HCV) infection. It is a combination of two drugs, nimasviir and daclatasvir. It is taken in combination with other HCV medicines, such as sofosbuvir or ribavirin. Nirmatrelvir prevents the virus from replicating and can be used to treat all genotypes of HCV. It is usually prescribed as a once-daily pill, taken with or without food.

Nirmatrelvir is an antiviral medication developed by Pfizer. It is important to note that Nirmatrelvir is not prescribed on its own. It's part of a combination medication called Paxlovid, which combines nirmatrelvir with another drug called ritonavir.

Here's a breakdown of Nirmatrelvir:

• Type of drug: Antiviral
• Brand name: Paxlovid (combination with ritonavir)
• Function: Treats mild-to-moderate COVID-19 in adults who are at high risk of complications
• How it works: Nirmatrelvir inhibits a SARS-CoV-2 enzyme called the main protease, which the virus needs to replicate.
• Paxlovid (Nirmatrelvir-Ritonavir) is not a substitute for vaccination.
• It is not recommended for people who are already hospitalized due to COVID-19.
• Do not take Paxlovid without consulting a doctor as it can interact with other medications.